Apolipoprotein News and Research

RSS
RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

Researchers identify genome-wide locus for serious gastrointestinal condition in infants

Researchers identify genome-wide locus for serious gastrointestinal condition in infants

Proteins involved in immunity produce cancer-causing DNA mutations, study finds

Proteins involved in immunity produce cancer-causing DNA mutations, study finds

Lipidation states in certain proteins in the brain differ depending on genotype, cognitive diseases

Lipidation states in certain proteins in the brain differ depending on genotype, cognitive diseases

EULAR announces recipients of Meritorious Service Award

EULAR announces recipients of Meritorious Service Award

Hypometabolism in brain regions of cognitively normal patients associated with Alzheimer's disease

Hypometabolism in brain regions of cognitively normal patients associated with Alzheimer's disease

Research: Anti-cancer drug tested as possible treatment for Alzheimer's disease proved ineffective

Research: Anti-cancer drug tested as possible treatment for Alzheimer's disease proved ineffective

FDA approves Mylan's ANDA for Fenofibrate Tablets

FDA approves Mylan's ANDA for Fenofibrate Tablets

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Isis Pharmaceuticals starts ISIS-APOARx Phase 1 clinical study for treatment of atherosclerosis

Isis Pharmaceuticals starts ISIS-APOARx Phase 1 clinical study for treatment of atherosclerosis

Combined genomic and proteomic plasma analysis can identify molecular disease mechanisms

Combined genomic and proteomic plasma analysis can identify molecular disease mechanisms

Apolipoprotein E-4 useful in promoting neuron growth in the lab

Apolipoprotein E-4 useful in promoting neuron growth in the lab

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

Accera commences clinical efficacy trial of AC-1204 for mild-to-moderate Alzheimer's disease

Accera commences clinical efficacy trial of AC-1204 for mild-to-moderate Alzheimer's disease

Computational apolipoprotein estimates ‘reliable’ for cardiovascular risk

Computational apolipoprotein estimates ‘reliable’ for cardiovascular risk

Computational apolipoprotein estimates  ‘reliable’ for CV risk

Computational apolipoprotein estimates ‘reliable’ for CV risk

New genetic insight into Alzheimer’s disease

New genetic insight into Alzheimer’s disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.